I-Salvianolic acid A CAS No. 96574-01-5
Ulwazi Olubalulekile
Isibizo:I-Salvianolic acid A, (2R) - 3 - (3,4-dihydroxyphenyl) - 2 - [(E) - 3 - [(E) - 2 - (3,4-dihydroxyphenyl) vinyl] - 3,4-dihydroxyphenyl] propyl-2-enoyl] oxypropionic acid, (2R) - 3 - (3,4-dihydroxyphenyl) - 2 - [(E) - 3 - [(E) - 2 - (3,4-dihydroxyphenyl) ethenyl] - 3 ,4-dihydroxyphenyl] prop-2-enoyl] oxypropionic acid
Inombolo ye-CAS:96574-01-5
Imodi yokutholwa:I-HPLC ≥ 98%
Imininingwane:20mg, 50mg, 100mg, 500mg, 1g (ingapakishwa ngokwezidingo zekhasimende)
Umlingiswa:Lo mkhiqizo uyikristalu ephuzi ngokukhanyayo
Umsebenzi kanye nokusetshenziswa:Lo mkhiqizo usetshenziselwa ukunquma okuqukethwe.
Umthombo wokukhipha:Lo mkhiqizo u-Salvia miltiorrhiza Bge Ezimpandeni ze.
Izici ze-Pharmacological:Incibilika ku-ethanol ne-ether.Iphoyinti lokuncibilika 315 ~ 323 ℃
Ukusetshenziswa:Izimo ze-Chromatographic: isigaba seselula: 45 methanol-1% amanzi e-acetic acid (45:55) izinga lokugeleza: 1ml/min ukutholwa kwe-wavelength: 286nm (ngokwereferensi kuphela)
Indlela Yesitoreji:2-8 ° C, gcina endaweni epholile neyomile futhi ugweme ukukhanya.
Izindaba Ezidinga Ukunakwa
Lo mkhiqizo kufanele ugcinwe ekushiseni okuphansi.Uma ivezwa emoyeni isikhathi eside, okuqukethwe kuzoncishiswa.
Ilungele i-angina pectoris kanye ne-acute myocardial infarction.Isebenza futhi ku-sequelae ye-cerebral thrombosis.Ngaphezu kwalokho, ingasetshenziswa futhi ekwelapheni i-thromboangiitis obliterans, i-scleroderma, i-embolism ye-retinal embolism, ubuthulu bezinzwa, i-white thiazide syndrome kanye ne-nodular erythema.
